In vivo assessment of safety of microneedle arrays in human skin.

Microneedle arrays are promising devices for the delivery of drugs and vaccines into or the skin. However, little is known about the safety of the microneedles. In this study we obtained insight in the ability of microneedles to disrupt the skin barrier, which was evaluated by transepidermal water loss (TEWL). We also determined the safety in terms of skin irritation (skin redness and blood flow) and pain sensation. We applied microneedle arrays varying in length and shape on the ventral forearms of 18 human volunteers. An effect of needle length was observed, as TEWL and redness values after treatment with solid microneedle arrays of 400 microm were significantly increased compared to 200 microm. The blood flow showed a similar trend. Needle design also had an effect. Assembled microneedle arrays induced higher TEWL values than the solid microneedle arrays, while resulting in less skin irritation. However, for all microneedles the irritation was minimal and lasted less than 2h. In conclusion, the microneedle arrays used in this study are able to overcome the barrier function of the skin in human volunteers, are painless and cause only minimal irritation. This opens the opportunity for dermal and transdermal delivery of drugs and vaccines.

[1]  T. Agner,et al.  Sodium lauryl sulphate for irritant patch testing--a dose-response study using bioengineering methods for determination of skin irritation. , 1990, The Journal of investigative dermatology.

[2]  Véronique Préat,et al.  Skin electroporation for transdermal and topical delivery. , 2004, Advanced drug delivery reviews.

[3]  Peter Elsner,et al.  Bioengineering of the skin : cutaneous blood flow and erythema , 1995 .

[4]  A. Ehrlacher,et al.  A new method to model change in cutaneous blood flow due to mechanical skin irritation part I: comparison between experimental and numerical data. , 2006, Journal of theoretical biology.

[5]  P. Andersen,et al.  Skin irritation in man: a comparative bioengineering study using improved reflectance spectroscopy , 1995, Contact dermatitis.

[6]  Aarti Naik,et al.  Iontophoretic drug delivery. , 2004, Advanced drug delivery reviews.

[7]  P. Elsner,et al.  Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo , 2005, The British journal of dermatology.

[8]  E. Tschachler,et al.  Analysis of circadian and ultradian rhythms of skin surface properties of face and forearm of healthy women. , 2001, The Journal of investigative dermatology.

[9]  C L Galli,et al.  Epidermal cytokines in experimental contact dermatitis. , 2000, Toxicology.

[10]  N. Romani,et al.  Langerhans cells – dendritic cells of the epidermis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[11]  S. Mitragotri,et al.  Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.

[12]  P. Elias,et al.  Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. , 1992, The Journal of clinical investigation.

[13]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[14]  Jung-Hwan Park,et al.  Tapered Conical Polymer Microneedles Fabricated Using an Integrated Lens Technique for Transdermal Drug Delivery , 2007, IEEE Transactions on Biomedical Engineering.

[15]  J. Bouwstra,et al.  Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Melissa Ai Ling Teo,et al.  In Vitro and In Vivo Characterization of MEMS Microneedles , 2005, Biomedical microdevices.

[17]  T. Luger,et al.  Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light , 1990, The Journal of experimental medicine.

[18]  J. Bouwstra,et al.  Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[19]  K. Wilhelm,et al.  Guidelines for measurement skin colour and erythema A report from the Standardization Group of the European Society of Contact Dermatitis * , 1996, Contact dermatitis.

[20]  P. Wollan,et al.  Making vaccines more acceptable--methods to prevent and minimize pain and other common adverse events associated with vaccines. , 2001, Vaccine.

[21]  J Serup,et al.  Guidelines for visualization of cutaneous blood flow by laser Doppler perfusion imaging , 2002, Contact dermatitis.

[22]  K. Sugibayashi,et al.  Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran. , 2006, International journal of pharmaceutics.

[23]  T. Agner,et al.  Guidelines for transepidermal water loss (TEWL) measurement , 1990, Contact dermatitis.

[24]  M. Danhof,et al.  Cutaneous side‐effects of transdermal iontophoresis with and without surfactant pretreatment: a single‐blinded, randomized controlled trial , 2005, The British journal of dermatology.

[25]  C. Meinhart,et al.  Bulk Micromachined Titanium Microneedles , 2007, Journal of Microelectromechanical Systems.

[26]  M. Cormier,et al.  Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. , 2006, Vaccine.

[27]  M. Singh,et al.  Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. , 2000, Current medicinal chemistry.

[28]  J. Matriano,et al.  Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.

[29]  R. Chilcott,et al.  Transepidermal water loss does not correlate with skin barrier function in vitro. , 2002, The Journal of investigative dermatology.

[30]  J. Kanitakis,et al.  Anatomy, histology and immunohistochemistry of normal human skin. , 2002, European journal of dermatology : EJD.

[31]  T. Kupper,et al.  Immunity at the surface: homeostatic mechanisms of the skin immune system. , 1996, Life sciences.

[32]  Wiendelt Steenbergen,et al.  Influence of optical properties and fiber separation on laser doppler flowmetry. , 2002, Journal of biomedical optics.

[33]  M. Allen,et al.  Lack of Pain Associated with Microfabricated Microneedles , 2001, Anesthesia and analgesia.

[34]  H. Maibach,et al.  Acute irritant contact dermatitis: recovery time in man , 1997, Contact dermatitis.

[35]  Mark R Prausnitz,et al.  Coated microneedles for transdermal delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[36]  H. Maibach,et al.  Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature. , 1998, The Journal of investigative dermatology.

[37]  G. Holloway,et al.  Laser Doppler measurement of cutaneous blood flow. , 1977, The Journal of investigative dermatology.

[38]  M Gloor,et al.  Testing for irritation with a multifactorial approach: comparison of eight non‐invasive measuring techniques on five different irritation types , 2001, The British journal of dermatology.

[39]  Henry,et al.  Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.

[40]  S. Kežić,et al.  Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate , 2006, Contact dermatitis.

[41]  Diane E. Sutter,et al.  Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.

[42]  Y. Nagase,et al.  Novel transdermal drug penetration enhancer: synthesis and enhancing effect of alkyldisiloxane compounds containing glucopyranosyl group. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[43]  Dorian Liepmann,et al.  Clinical microneedle injection of methyl nicotinate: stratum corneum penetration , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[44]  Mark R Prausnitz,et al.  Microneedles permit transdermal delivery of a skin-impermeant medication to humans , 2008, Proceedings of the National Academy of Sciences.

[45]  D. Liepmann,et al.  Arrays of hollow out-of-plane microneedles for drug delivery , 2005, Journal of Microelectromechanical Systems.

[46]  T. Luger,et al.  Effect of UV irradiation on epidermal cell cytokine production. , 1989, Journal of photochemistry and photobiology. B, Biology.

[47]  E. Corsini,et al.  Cytokines and irritant contact dermatitis. , 1998, Toxicology letters.